Summit Therapeutics SMMT
$9.95 −$0.62 (-5.87%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $10.08 +1.31%
Open$10.28
Prev close$10.57
Day range$9.89 – $10.61
Volume7.22M
Market cap$7.96B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts13
Average target$27.57+177.1% vs. price
- Buy 62%
- Hold 31%
- Sell 8%
Low $8.30Now $9.95Avg $27.57High $43.00
Recent rating changes
The last 20 actions on file set price targets from $8.30 to $43.00, averaging $30.29.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 19 Nov 2026 | Leerink Partners | HOLD | $11.00 |
| 18 Nov 2026 | Bernstein | SELL | $8.30 |
| 18 Nov 2026 | Leerink Partners | HOLD | – |
| 17 Nov 2026 | H.C. Wainwright | HOLD | – |
| 16 Nov 2026 | Piper Sandler | HOLD | $16.00 |
| 16 Nov 2026 | Stifel | BUY | $37.00 |
| 16 Nov 2026 | Citi | BUY | $42.00 |
| 16 Nov 2026 | H.C. Wainwright | HOLD | – |
| 16 Nov 2026 | Barclays | HOLD | $18.00 |
| 15 Nov 2026 | Wells Fargo | BUY | $30.00 |
| 15 Nov 2026 | Citi | BUY | $42.00 |
| 15 Nov 2026 | Goldman Sachs | BUY | $43.00 |
| 11 Nov 2026 | Wells Fargo | BUY | $30.00 |
| 5 Nov 2026 | Evercore | BUY | $34.00 |
| 5 Nov 2026 | Stifel | BUY | $37.00 |
| 5 Nov 2026 | Citi | BUY | $43.00 |
| 5 Nov 2026 | H.C. Wainwright | HOLD | – |
| 4 Nov 2026 | Goldman Sachs | BUY | $43.00 |
| 4 Nov 2026 | Barclays | HOLD | $20.00 |
| 2 Nov 2026 | H.C. Wainwright | HOLD | – |
No comments yet — be the first to weigh in on SMMT.
Sign in to join the discussion.